Higher Ed on the Hill: Joe v. Kamala – Different Ticket, Same Tune
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. Up...
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. Up...
Welcome back to Higher Ed on the Hill where we break down the top news driving higher education policy. Up...
Higher Ed on the Hill: Is College Worth It & Rep. Owens Introduces Bill to Enhance Access to Higher Education...
Welcome back to Higher Ed on the Hill, where we break down the top policies driving higher education policy. On...
Welcome back to another edition of Higher Ed on the Hill, where we break down the top issues facing higher...
The United States has a vibrant higher education system that offers students of all backgrounds an opportunity to earn a...
Alexandria, Virginia — Today CASE issued the following endorsement letter in strong support of H.R. 6951, the College Cost...
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. In...
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. Up...
November 10, 2023 Newest Front in Biden’s Crusade on Career Colleges Welcome back to Higher Ed on the Hill...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/